News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
L’Oreal Independently Validates ProtoKinetix Inc.'s AAGP(TM) Cosmetic Application
July 22, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
VANCOUVER--(BUSINESS WIRE)--ProtoKinetix (PKTX) announces that L’Oreal (LOR) has applied for a patent using the ProtoKinetix’ Anti-Aging Glyco Peptide (AAGP™) family of molecules as the basis for a skin lightening agent.
Twitter
LinkedIn
Facebook
Email
Print